Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers

NCT00740922 · clinicaltrials.gov ↗

COMPLETED

Status

563

Enrollment

INDUSTRY

Sponsor class

Conditions

Platelet-Derived Growth Factor
Diabetic Foot
Neoplasms

Interventions

DRUG: Sterile becaplermin gel vs. sterile placebo gel treatment 1

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.